Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Ascent CEO Colin Hutchinson with latest on review and permitting Watch Here

EXCLUSIVE: Ascent CEO Colin Hutchinson with latest on review and permitting


Advanced Onco Share Price (AVO)



Share Price Information for Advanced Onco (AVO)


Share Price: 50.00Bid: 48.00Ask: 52.00Change: 0.00 (0.00%)No Movement on Advanced Onco
Spread: 4.00Spread as %: 8.33%Open: 50.00High: 50.00Low: 50.00Yesterday’s Close: 50.00

Advanced Oncotherapy Plc Ord 25P

Advanced Onco is listed in the FTSE AIM All-Share
Advanced Onco is part of the Health Care and Related Services sector

Advanced Onco is part of the Real Estate Investment & Services sector





Share Price SpacerPrice
50.00
Share Price SpacerBid
48.00
Share Price SpacerAsk
52.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
15,177
Share Price SpacerOpen
50.00
Share Price SpacerHigh
50.00
Share Price SpacerLow
50.00
Share Price SpacerClose
50.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 155.63m £77.81m 4,000

52 Week High 63.50 52 Week High Date 27-APR-2018
52 Week Low 15.00 52 Week Low Date 1-SEP-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
6 0 14,957 -2.849 -17.55 0.00 0.00


London South East Users info for Advanced Onco




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

15-Aug-18
14:20:48
51.30
9,746
Buy* 
48.00
52.00
5,000
Trade Type:
Ordinary

15-Aug-18
13:53:30
51.30
2,000
Buy* 
48.00
52.00
1,026
Trade Type:
Ordinary

15-Aug-18
10:26:48
51.30
1,237
Buy* 
48.00
52.00
634.58
Trade Type:
Ordinary




View more Advanced Onco trades >>

Directors Deals for Advanced Onco (AVO)
Trade DateActionNotifierPriceCurrencyAmountHolding
31-Jul-17Buy
Trade Notifier Information for Advanced Oncotherapy
Enrico Cipro Vanni held the position of Non-Executive Director at Advanced Oncotherapy at the time of this trade.
 Enrico Cipro Vanni
17.75GBX100,0001223946
15-May-17Buy
Trade Notifier Information for Advanced Oncotherapy
Steve Myers OBE held the position of Non-Executive Director at Advanced Oncotherapy at the time of this trade.
 Steve Myers OBE
26GBX400,000450569
09-May-17Buy
Trade Notifier Information for Advanced Oncotherapy
Christopher Nutting held the position of Non-Executive Director at Advanced Oncotherapy at the time of this trade.
 Christopher Nutting
24.67GBX202,500217316
View more Advanced Onco directors dealings >>


Ian1234
Posts: 437
Opinion:No Opinion
Price:50.00
RE: 3 shares
Wed 14:10
In case you’re not aware, news is due by the end of this quarter. DYOR.
afrc
Posts: 395
Opinion:No Opinion
Price:50.00
RE: 3 shares
Wed 13:35
I am sorry to say that, but investing in the stockmarket in not related to resisting a temptation ie eating chocolate.The longer we dont get any seriously good news, the lower the sp will drift down, and the way the co is burning up cash, soon it will need more propping up AGAIN .
Ian1234
Posts: 437
Opinion:No Opinion
Price:50.00
RE: 3 shares
Wed 11:15
Couldn’t resist topping up. Surely with this news due it’s rock bottom.
max19
Posts: 2,616
Opinion:No Opinion
Price:49.50
RE: 3 shares
Tue 11:19
Few buyers making the most of the Summer sale....
Ian1234
Posts: 437
Opinion:No Opinion
Price:49.50
RE: 3 shares
Tue 11:08
Bargain basement price right here with news due by end of Sept!!
View more share chat for Advanced Onco (AVO) >>




Website: Advanced Oncotherapy Plc Ord 25P
Website Description: www.advancedoncotherapy.com



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.